These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5050442)

  • 1. The concurrent effects of scopolamine on spontaneous motor activity and the acquisition of an active avoidance response.
    Reinfro CT; Freedman PE; Rosen AJ
    Neuropharmacology; 1972 May; 11(3):337-46. PubMed ID: 5050442
    [No Abstract]   [Full Text] [Related]  

  • 2. Task-dependent development of tolerance to scopolamine.
    Rosic N; Bokonjic D; Overstreet DH
    Pharmacol Biochem Behav; 1980 Aug; 13(2):183-6. PubMed ID: 7413688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of scopolamine on activity and passive avoidance learning in rats of different ages.
    Feigley DA
    J Comp Physiol Psychol; 1974 Jul; 87(1):26-36. PubMed ID: 4413163
    [No Abstract]   [Full Text] [Related]  

  • 4. An analysis of the facilitation of avoidance acquisition produced by d-amphetamine and scopolamine.
    Barrett RJ; Leith NJ; Ray OS
    Behav Biol; 1974 Jun; 11(2):189-203. PubMed ID: 4847521
    [No Abstract]   [Full Text] [Related]  

  • 5. Scopolamine: effects on conditioned suppression.
    Smith AA; Calhoun WH
    Neuropharmacology; 1972 May; 11(3):347-50. PubMed ID: 5050443
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquisition and performance effects of scopolamine and of treatment withdrawal in avoidance situations.
    Bignami G; Rosić N
    Physiol Behav; 1972 Jun; 8(6):1127-34. PubMed ID: 5074027
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of scopolamine and atropine on the performance of an exercise-avoidance test by dogs.
    Mennear JH; Samuel GK; Joffe MH; Kodama JK
    Psychopharmacologia; 1966; 9(4):347-50. PubMed ID: 5996940
    [No Abstract]   [Full Text] [Related]  

  • 8. DAU 6215, a novel 5-HT3-receptor antagonist, selectively antagonizes scopolamine-induced deficit in a passive-avoidance task, but not scopolamine-induced hypermotility in rats.
    Brambilla A; Ghiorzi A; Pitsikas N; Borsini F
    J Pharm Pharmacol; 1993 Sep; 45(9):841-3. PubMed ID: 7903377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of molsidomine on scopolamine-induced amnesia and hypermotility in the rat.
    Pitsikas N; Rigamonti AE; Cella SG; Locatelli V; Sala M; Muller EE
    Eur J Pharmacol; 2001 Aug; 426(3):193-200. PubMed ID: 11527544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative and positive effects of intracerebroventricular scopolamine on memory in mice undergoing passive avoidance and escape tests.
    Nakajima M; Inui A; Miura M; Hirosue Y; Okita M; Himori N; Baba S; Kasuga M
    Brain Res Bull; 1994; 34(4):375-80. PubMed ID: 8082028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
    Riekkinen P
    Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the effects of scopolamine and diazepam on acquisition and retention of inhibitory avoidance in mice.
    Decker MW; Tran T; McGaugh JL
    Psychopharmacology (Berl); 1990; 100(4):515-21. PubMed ID: 2320713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scopolamine's effect on passive avoidance behavior in immature rats.
    Wilson LM; Riccio DC
    Dev Psychobiol; 1976 May; 9(3):245-54. PubMed ID: 955285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent vs real effects of scopolamine on the learning of an active avoidance task.
    Vinader-Caerols C; Aguilar MA; Pérez-Iranzo N; Miñarro J; Parra A; Simón VM
    Neurobiol Learn Mem; 1996 Sep; 66(2):246-51. PubMed ID: 8946418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor activity changes and conditioned taste aversions induced by administration of scopolamine in rats: role of the area postrema.
    Ossenkopp KP; Sutherland C; Ladowsky RL
    Pharmacol Biochem Behav; 1986 Jul; 25(1):269-76. PubMed ID: 3749232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metrifonate improves spatial navigation and avoidance behavior in scopolamine-treated, medial septum-lesioned and aged rats.
    Riekkinen P; Schmidt B; Stefanski R; Kuitunen J; Riekkinen M
    Eur J Pharmacol; 1996 Aug; 309(2):121-30. PubMed ID: 8874130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scopolamine and acquisition of go-no go avoidance: a further analysis of the perseverative antimuscarinic deficit.
    Giardini V; Amorico L; De Acetis L; Bignami G
    Psychopharmacology (Berl); 1983; 80(2):131-7. PubMed ID: 6410441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavioral effects of propentofylline (HWA 285) on ambulatory activity, discrete avoidance response and passive avoidance response in mice].
    Kuribara H; Tadokoro S; Haraguchi H
    Nihon Yakurigaku Zasshi; 1986 May; 87(5):573-81. PubMed ID: 3732965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential attenuation of some effects of haloperidol in rats given scopolamine.
    Setler P; Sarau H; McKenzie G
    Eur J Pharmacol; 1976 Sep; 39(1):117-26. PubMed ID: 986946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging cholinergic mechanisms and ontogeny of response inhibition in the mouse.
    Ray D; Nagy ZM
    J Comp Physiol Psychol; 1978 Apr; 92(2):335-49. PubMed ID: 670457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.